Table 1.
Maximal fitted response and potency of ACh and NS9283 from wild-type and concatenated α4β2 nAChRs
ConstructSubunitAChNS9283Both
EmaxpEC50_1pEC50_2FracnE31.6 µMEmaxpEC50nAChmax current
  %      % %    nA 
α4 (10:1) β2 102 ± 1 5.7 ± 0.3 3.9 ± 0.04 0.11 ± 0.03 14  760 ± 70 860 ± 60 5.3 ± 0.1 13  8,100 ± 900 (27) 
α4VFL (10:1) β2 104 ± 2 5.0 ± 0.1 3.9 ± 0.3 0.71 ± 0.12  −9.9 ± 1.8 No pos. pot. N/A 16  1,700 ± 300 (25) 
β-6-α  102 ± 2 5.8 ± 0.3 3.6 ± 0.1 0.11 ± 0.02  640 ± 90 900 ± 140 4.9 ± 0.2  1,000 ± 300 (18) 
β-6-α α4 101 ± 2 5.7 ± 0.6 3.8 ± 0.1 0.073 ± 0.038 10  860 ± 100 1,100 ± 100 5.1 ± 0.2 12  5,200 ± 800 (22) 
β-6-α α4VFL 106 ± 2 5.2 ± 0.2 3.8 ± 0.1 0.40 ± 0.08 12  210 ± 20 270 ± 30 5.0 ± 0.1  2,200 ± 400 (19) 
β-6-α (1:25) α4VFL 106 ± 1 5.3 ± 0.1 4.0 ± 0.1 0.39 ± 0.05  240 ± 20 300 ± 30 5.1 ± 0.1  1,200 ± 200 (12) 
β-9a-α  105 ± 3 5.7 ± 0.2 3.9 ± 0.1 0.28 ± 0.05 11  100 ± 20 130 ± 30 5.0 ± 0.3  220 ± 60 (16) 
β-9a-α α4 103 ± 3 5.6 ± 0.4 3.7 ± 0.1 0.13 ± 0.05  680 ± 40 950 ± 80 4.9 ± 0.1  3,000 ± 600 (14) 
β-9a-α α4VFL 109 ± 5 5.3 ± 0.3 3.7 ± 0.2 0.32 ± 0.09  200 ± 10 260 ± 20 5.0 ± 0.1  2,600 ± 1,000 (13) 
β-6a-α  103 ± 2 5.8 ± 0.1 4.5 ± 0.4 0.70 ± 0.12  45 ± 9 51 ± 7 5.4 ± 0.2  94 ± 18 (12)a 
β-6a-α α4 100 ± 1 6.1 ± 0.4 3.9 ± 0.04 0.059 ± 0.018 10  710 ± 50 870 ± 60 5.1 ± 0.1  1,800 ± 300 (16) 
β-6a-α α4VFL 105 ± 3 5.6 ± 0.4 4.2 ± 0.2 0.31 ± 0.14  140 ± 10 180 ± 10 5.0 ± 0.1  170 ± 40 (15) 
β-3a-α  103 ± 1 5.7 ± 0.1 4.5 ± 0.2 0.64 ± 0.11 14  7.5 ± 8.2 Inconclusive N/A 11  120 ± 30 (25)b 
β-3a-α α4 102 ± 1 5.7 ± 0.2 4.0 ± 0.03 0.11 ± 0.02 17  610 ± 30 720 ± 30 5.2 ± 0.1 18  1,500 ± 200 (35) 
β-3a-α α4VFL 104 ± 1 5.7 ± 0.1 4.4 ± 0.1 0.41 ± 0.06 17  22 ± 3 27 ± 4 5.2 ± 0.2 24  890 ± 130 (41) 
β-0a-α  N/A N/A N/A N/A N/A  N/A N/A N/A N/A  15 ± 4 (24)c 
β-0a-α α4 103 ± 2 5.8 ± 0.7 3.7 ± 0.05 0.053 ± 0.028 11  840 ± 90 1,100 ± 100 5.0 ± 0.1  130 ± 40 (20)d 
β-0a-α α4VFL 101 ± 1 5.4 ± 0.5 4.6 ± 0.2 0.28 ± 0.34 14  −6.0 ± 2.4 No pos. pot. N/A 15  95 ± 18 (29)d 
β-(-3a)-α  N/A N/A N/A N/A N/A  N/A N/A N/A N/A  No current (18) 
β-(-3a)-α α4 N/A N/A N/A N/A N/A  N/A N/A N/A N/A  36 ± 6 (27) 
β-(-3a)-α α4VFL N/A N/A N/A N/A N/A  N/A N/A N/A N/A   15 ± 2 (21) 
ConstructSubunitAChNS9283Both
EmaxpEC50_1pEC50_2FracnE31.6 µMEmaxpEC50nAChmax current
  %      % %    nA 
α4 (10:1) β2 102 ± 1 5.7 ± 0.3 3.9 ± 0.04 0.11 ± 0.03 14  760 ± 70 860 ± 60 5.3 ± 0.1 13  8,100 ± 900 (27) 
α4VFL (10:1) β2 104 ± 2 5.0 ± 0.1 3.9 ± 0.3 0.71 ± 0.12  −9.9 ± 1.8 No pos. pot. N/A 16  1,700 ± 300 (25) 
β-6-α  102 ± 2 5.8 ± 0.3 3.6 ± 0.1 0.11 ± 0.02  640 ± 90 900 ± 140 4.9 ± 0.2  1,000 ± 300 (18) 
β-6-α α4 101 ± 2 5.7 ± 0.6 3.8 ± 0.1 0.073 ± 0.038 10  860 ± 100 1,100 ± 100 5.1 ± 0.2 12  5,200 ± 800 (22) 
β-6-α α4VFL 106 ± 2 5.2 ± 0.2 3.8 ± 0.1 0.40 ± 0.08 12  210 ± 20 270 ± 30 5.0 ± 0.1  2,200 ± 400 (19) 
β-6-α (1:25) α4VFL 106 ± 1 5.3 ± 0.1 4.0 ± 0.1 0.39 ± 0.05  240 ± 20 300 ± 30 5.1 ± 0.1  1,200 ± 200 (12) 
β-9a-α  105 ± 3 5.7 ± 0.2 3.9 ± 0.1 0.28 ± 0.05 11  100 ± 20 130 ± 30 5.0 ± 0.3  220 ± 60 (16) 
β-9a-α α4 103 ± 3 5.6 ± 0.4 3.7 ± 0.1 0.13 ± 0.05  680 ± 40 950 ± 80 4.9 ± 0.1  3,000 ± 600 (14) 
β-9a-α α4VFL 109 ± 5 5.3 ± 0.3 3.7 ± 0.2 0.32 ± 0.09  200 ± 10 260 ± 20 5.0 ± 0.1  2,600 ± 1,000 (13) 
β-6a-α  103 ± 2 5.8 ± 0.1 4.5 ± 0.4 0.70 ± 0.12  45 ± 9 51 ± 7 5.4 ± 0.2  94 ± 18 (12)a 
β-6a-α α4 100 ± 1 6.1 ± 0.4 3.9 ± 0.04 0.059 ± 0.018 10  710 ± 50 870 ± 60 5.1 ± 0.1  1,800 ± 300 (16) 
β-6a-α α4VFL 105 ± 3 5.6 ± 0.4 4.2 ± 0.2 0.31 ± 0.14  140 ± 10 180 ± 10 5.0 ± 0.1  170 ± 40 (15) 
β-3a-α  103 ± 1 5.7 ± 0.1 4.5 ± 0.2 0.64 ± 0.11 14  7.5 ± 8.2 Inconclusive N/A 11  120 ± 30 (25)b 
β-3a-α α4 102 ± 1 5.7 ± 0.2 4.0 ± 0.03 0.11 ± 0.02 17  610 ± 30 720 ± 30 5.2 ± 0.1 18  1,500 ± 200 (35) 
β-3a-α α4VFL 104 ± 1 5.7 ± 0.1 4.4 ± 0.1 0.41 ± 0.06 17  22 ± 3 27 ± 4 5.2 ± 0.2 24  890 ± 130 (41) 
β-0a-α  N/A N/A N/A N/A N/A  N/A N/A N/A N/A  15 ± 4 (24)c 
β-0a-α α4 103 ± 2 5.8 ± 0.7 3.7 ± 0.05 0.053 ± 0.028 11  840 ± 90 1,100 ± 100 5.0 ± 0.1  130 ± 40 (20)d 
β-0a-α α4VFL 101 ± 1 5.4 ± 0.5 4.6 ± 0.2 0.28 ± 0.34 14  −6.0 ± 2.4 No pos. pot. N/A 15  95 ± 18 (29)d 
β-(-3a)-α  N/A N/A N/A N/A N/A  N/A N/A N/A N/A  No current (18) 
β-(-3a)-α α4 N/A N/A N/A N/A N/A  N/A N/A N/A N/A  36 ± 6 (27) 
β-(-3a)-α α4VFL N/A N/A N/A N/A N/A  N/A N/A N/A N/A   15 ± 2 (21) 

X. laevis oocytes were injected with the indicated cRNA mixtures in a 1:1 ratio (unless otherwise indicated) and subjected to two-electrode voltage-clamp electrophysiology after 2–3 d of incubation time as described in Materials and methods; also see Fig. 1. Data points were fitted to either a monophasic or a biphasic equation with the bottom set to 0 and a Hill slope set to 1 by nonlinear regression. For ACh, biphasic fitting represented the preferred model for all datasets as determined by an F test. Fitted maximal responses of ACh and NS9283 are presented as Emax ± SEM in percentages, with associated potencies presented as pEC50 ± SEM in M for the indicated number of individual oocytes. Observed NS9283 responses at the 31.6-μM concentration are presented as E31.6 μM ± SEM in percentages. The mean maximal current obtained with applications of 3.16 mM ACh is presented as AChmax current ± SEM in nanoamperes for all tested oocytes for each construct. N/A, not applicable; No pos. pot., no positive potentiation; Inconclusive, meaningful fitting not possible, as only ∼50% of the oocytes displayed a positive NS9283 response.

a

Selected oocytes due to low AChmax-evoked current amplitudes.

b

No AChmax-evoked currents in approximately three out of four oocytes.

c

Only two oocytes show >25 nA AChmax-evoked current amplitude.

d

Mixture of oocytes from 3 and 5 d of incubation.

or Create an Account

Close Modal
Close Modal